Literature DB >> 170342

Anomalous reactions of mouse alloantisera with cultured tumor cells. II. Cytotoxicity is caused by antibodies to leukemia viruses.

R C Nowinski, P A Klein.   

Abstract

Certain alloantisera prepared in mice against H-2 region membrane antigens were found to be unexpectedly cytotoxic for murine sarcoma and leukemia cells in culture. This anomalous cytotoxicity was shown to be the result of antibody in these alloantisera directed against the p15 and gp70 envelope proteins of Mu LV which were present on the surface of the tumor target cells. Sera from aged unimmunized mice of strains used for the preparation of alloantisera also contained antibodies against MuLV protein p15 and gp70 that were cytotoxic for sarcoma and leukemia cells, which indicates that these antibodies occurred naturally in mice. These results independently confirm earlier findings of the widespread occurrence in mouse serum of antibodies reactive with MuLV. The presence of antibody against MuLV in mouse serum which can cause cytotoxic reactions with tumor cells points to the fact that particular caution should be used during the typing of murine sarcomas or leukemias for cell surface antigens, since mouse antisera may yield cytotoxicity (or other serologic reactions) based on anti-MuLV specificities, rather than on anticipated antigens.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170342

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Anti-H-2 antibodies induced by syngeneic immunization.

Authors:  P Iványi; P van Mourik; M Breuning; C J Melief
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

2.  Antigen-liposome modification of target cells as a method to alter their susceptibility to lysis by cytotoxic T lymphocytes.

Authors:  A H Hale; M J Ruebush; D S Lyles; D T Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

3.  Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts.

Authors:  C C Zielinski; S K Datta; S D Waksal
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

4.  Genetic control of cross-reactive cytotoxic T-lymphocyte responses to a BALB/c tumor.

Authors:  J H Russell; C B Dobos; R J Graff; B A Taylor
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

5.  Autoimmunity induced by injection of virus-modified cell membrane antigens in syngeneic mice.

Authors:  M D Eaton; S J Almquist
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

6.  Identification of a fourth class of proteins linked to the murine major histocompatibility complex.

Authors:  J J Monaco; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

7.  Natural immunity in mice to the envelope glycoprotein of endogenous ecotropic type C viruses: neutralization of virus infectivity.

Authors:  J N Ihle; B Lazar
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

8.  Biochemical evidence for a separate, MHC-linked locus encoding H-2.28 antigens.

Authors:  D W Sears; C M Polizzi
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

9.  Variation of expression of histocompatibility antigens on tumor cells: absence of H-2Kk-gene products from a gross-virus-induced leukemia in BALB.K.

Authors:  W Schmidt; L Leben; G Atfield; H Festenstein
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

10.  Potentiation of a primary in vivo antibody response by alloantisera against gene products of the I region of the H-2 complex.

Authors:  M Pierres; R N Germain; M E Dorf; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.